Hasil Pencarian - Ashutosh D. Wechalekar
- Menampilkan 1 - 14 hasil dari 14
-
1
-
2
Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... oleh Ashutosh D. Wechalekar, Julian D. Gillmore, Nancy Wassef, Helen J. Lachmann, Carol Whelan, Philip N. Hawkins
Diterbitkan 2011-07-01Dapatkan teks lengkap
Artikel -
3
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis oleh Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, Jessica Vermeulen, Eric Ammann, Annette Lam, Sarah Cote, Ashutosh D. Wechalekar
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel -
4
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis oleh Sajitha Sachchithanantham, Mark Offer, Christopher Venner, Shameem A. Mahmood, Darren Foard, Lisa Rannigan, Thirusha Lane, Julian D. Gillmore, Helen J. Lachmann, Philip N. Hawkins, Ashutosh D. Wechalekar
Diterbitkan 2015-11-01Dapatkan teks lengkap
Artikel -
5
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria oleh Faye A. Sharpley, Marianna Fontana, Ana Martinez-Naharro, Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Julian D. Gillmore, Carol J. Whelan, Philip N. Hawkins, Ashutosh D. Wechalekar
Diterbitkan 2020-05-01Dapatkan teks lengkap
Artikel -
6
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib oleh Sriram Ravichandran, Oliver C. Cohen, Steven Law, Darren Foard, Marianna Fontana, Ana Martinez-Naharro, Carol Whelan, Julian D. Gillmore, Helen J. Lachmann, Sajitha Sachchithanantham, Shameem Mahmood, Philip N. Hawkins, Ashutosh D. Wechalekar
Diterbitkan 2021-06-01Dapatkan teks lengkap
Artikel -
7
The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis oleh Tamer Rezk, Janet A Gilbertson, P Patrizia Mangione, Dorota Rowczenio, Nigel B Rendell, Diana Canetti, Helen J Lachmann, Ashutosh D Wechalekar, Paul Bass, Philip N Hawkins, Vittorio Bellotti, Graham W Taylor, Julian D Gillmore
Diterbitkan 2019-07-01Dapatkan teks lengkap
Artikel -
8
A prospective study of nutritional status in immunoglobulin light chain amyloidosis oleh Prayman T. Sattianayagam, Thirusha Lane, Zoe Fox, Aviva Petrie, Simon D.J. Gibbs, Jennifer H. Pinney, Signe S. Risom, Dorota M. Rowczenio, Ashutosh D. Wechalekar, Helen J. Lachmann, Janet A. Gilbertson, Philip N. Hawkins, Julian D. Gillmore
Diterbitkan 2013-01-01Dapatkan teks lengkap
Artikel -
9
Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting oleh Christopher P. Venner, Julian D. Gillmore, Sajitha Sachchithanantham, Shameem Mahmood, Thirusha Lane, Darren Foard, Murielle Roussel, Lisa Rannigan, Simon DJ Gibbs, Jennifer H Pinney, Carol J. Whelan, Helen J. Lachmann, Philip N. Hawkins, Ashutosh D. Wechalekar
Diterbitkan 2014-12-01Dapatkan teks lengkap
Artikel -
10
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis oleh Vikram J. Premkumar, Suzanne Lentzsch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath, Michaela Liedtke, Arnaud Jaccard, Ashutosh D. Wechalekar, Raymond Comenzo, Vaishali Sanchorawala, Bruno Royer, Michael Rosenzweig, Jason Valent, Stefan Schönland, Rafael Fonseca, Sandy Wong, Prashant Kapoor
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
11
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III) oleh Arnaud Jaccard, Raymond L. Comenzo, Parameswaran Hari, Philip N. Hawkins, Murielle Roussel, Pierre Morel, Margaret Macro, Jean-Luc Pellegrin, Estibaliz Lazaro, Dania Mohty, Patrick Mercie, Olivier Decaux, Julian Gillmore, David Lavergne, Frank Bridoux, Ashutosh D. Wechalekar, Christopher P. Venner
Diterbitkan 2014-09-01Dapatkan teks lengkap
Artikel -
12
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma oleh Catherine S. Y. Lecat, Catherine S. Y. Lecat, Jessica B. Taube, William Wilson, Jonathan Carmichael, Jonathan Carmichael, Christopher Parrish, Gabriel Wallis, Charalampia Kyriakou, Lydia Lee, Shameem Mahmood, Xenofon Papanikolaou, Neil K. Rabin, Jonathan Sive, Ashutosh D. Wechalekar, Kwee Yong, Gordon Cook, Gordon Cook, Rakesh Popat
Diterbitkan 2021-07-01Dapatkan teks lengkap
Artikel -
13
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis oleh Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Anish Tailor, Kwee Yong, Rakesh Popat, Neil Rabin, Charalampia Kyriakou, Jonathan Sive, Simona Degli Esposti, Daniel F. P. Larkin, Sarah Worthington, Alyse Hart, Emma Dowling, Nuno Correia, Ceri Bygrave, Andrzej Rydzewski, Krzysztof Jamroziak, Ashutosh D. Wechalekar
Diterbitkan 2022-09-01Dapatkan teks lengkap
Artikel -
14
Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein oleh Dorota Rowczenio, Maria Stensland, Gustavo A. de Souza, Erik H. Strøm, Janet A. Gilbertson, Graham Taylor, Nigel Rendell, Shane Minogue, Yvonne A. Efebera, Helen J. Lachmann, Ashutosh D. Wechalekar, Philip N. Hawkins, Ketil R. Heimdal, Kristian Selvig, Inger K. Lægreid, Nathalie Demoulin, Selda Aydin, Julian D. Gillmore, Tale N. Wien
Diterbitkan 2017-05-01Dapatkan teks lengkap
Artikel